Gonzalez Richard A's Form 4 filing
AbbVie Inc. (ABBV) · filed Mar 4, 2025
- Accession no.
- 0001415889-25-006579
- Filed
- Mar 4, 2025
- Trade date
- Feb 28-Mar 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $20.3M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gonzalez Richard ACIK 0001239127 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Common Stock, $0.01 par value | FTax withholdingDisposed | −73,209 | $205.02 | −$15,009,309.18 | 487,557 | Direct | |
| Feb 28, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −92,460 | $205.11 | −$18,964,470.6 | 395,097 | Direct | |
| Mar 3, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −6,168 | $210.53 | −$1,298,549.04 | 388,929 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.